probably end up doing an URM.. good for holders who got in early - but not for those who bought at the top... time will tell :)
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025